Physician profile
Benjamin Samstein
NPI 1164463733
$10,764.24
in general payments reported to CMS, 2019-2025
9 companies · $1,501 in 2025
The $1,501 reported for 2025 was more than what 78% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $18.26 · 2022: $3,730 · 2023: $996 · 2024: $4,519 · 2025: $1,501.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,826 · Food and Beverage: $2,190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,825.51 |
| Food and Beverage | $2,190.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,331.70 | 2022-2024 | Da Vinci Surgical System |
| Transmedics, INC. | $2,975.54 | 2024-2025 | Organ Care System |
| Histosonics, INC. | $2,685.02 | 2024 | |
| Olympus America INC. | $304.46 | 2022-2023 | Visera Elite II Video System Center Olympus Otv-S300, Olympus |
| Ethicon US, LLC | $185.79 | 2023-2025 | Echelon; Endopath |
| Organox LTD | $171.76 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $91.71 | 2025 | Nulojix |
| Gilead Sciences, INC. | $18.26 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Samstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.